• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Transitioning from guideline approval to practical implementation of AUC-based monitoring of vancomycin.

作者信息

Bland Christopher M, Crosby Courtney M, Orvin Dustin L, Smith Susan E, Jones Bruce M

机构信息

University of Georgia College of Pharmacy Savannah, GA.

St. Joseph's/Candler Health System, Inc. Savannah, GA.

出版信息

Am J Health Syst Pharm. 2021 Jul 9;78(14):1270-1272. doi: 10.1093/ajhp/zxab132.

DOI:10.1093/ajhp/zxab132
PMID:33772267
Abstract
摘要

相似文献

1
Transitioning from guideline approval to practical implementation of AUC-based monitoring of vancomycin.从万古霉素基于血药浓度-时间曲线下面积（AUC）监测的指南批准到实际实施的转变。
Am J Health Syst Pharm. 2021 Jul 9;78(14):1270-1272. doi: 10.1093/ajhp/zxab132.
2
Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-No.基于浓度-时间曲线下的万古霉素面积的治疗药物监测是否应该成为严重耐甲氧西林金黄色葡萄球菌感染的标准？-否。
Clin Infect Dis. 2021 May 4;72(9):1502-1506. doi: 10.1093/cid/ciaa1743.
3
Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.万古霉素曲线下面积指导剂量和监测成人和儿童疑似或确诊严重耐甲氧西林金黄色葡萄球菌感染患者：把我们患者的安全放在首位。
Clin Infect Dis. 2021 May 4;72(9):1497-1501. doi: 10.1093/cid/ciaa1744.
4
Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.实施基于两点药代动力学 AUC 的万古霉素治疗药物监测方法在耐甲氧西林金黄色葡萄球菌菌血症患者中的应用。
Int J Antimicrob Agents. 2018 Dec;52(6):805-810. doi: 10.1016/j.ijantimicag.2018.08.024. Epub 2018 Aug 31.
5
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.治疗侵袭性耐甲氧西林金黄色葡萄球菌感染所需的万古霉素谷浓度。
Pediatr Infect Dis J. 2013 Oct;32(10):1077-9. doi: 10.1097/INF.0b013e318299f75c.
6
Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Bacteremia.万古霉素药时曲线下面积给药与谷浓度目标值给药在肥胖与非肥胖耐甲氧西林金黄色葡萄球菌菌血症患者中的比较。
Ann Pharmacother. 2020 Jul;54(7):644-651. doi: 10.1177/1060028019897100. Epub 2019 Dec 30.
7
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会修订的共识指南及综述
Clin Infect Dis. 2020 Sep 12;71(6):1361-1364. doi: 10.1093/cid/ciaa303.
8
Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.从基于万古霉素谷浓度的给药方案转换为基于曲线下面积的给药方案：在成人中使用两次样本测量的实施。
Pharmacotherapy. 2019 Apr;39(4):433-442. doi: 10.1002/phar.2234. Epub 2019 Mar 18.
9
Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.耐甲氧西林金黄色葡萄球菌血流感染患者中，第1天和第2天万古霉素曲线下面积值与采用Etest®宏方法检测的异质性万古霉素中介金黄色葡萄球菌（hVISA）出现之间的关系：一项初步研究。
BMC Infect Dis. 2017 Aug 2;17(1):534. doi: 10.1186/s12879-017-2609-0.
10
Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?平衡万古霉素的疗效与肾毒性：我们应该以谷浓度还是AUC/MIC为目标？
Paediatr Drugs. 2015 Apr;17(2):97-103. doi: 10.1007/s40272-015-0117-5.

引用本文的文献

1
Impact of Pharmacist-Led Anti-Infective Consultations on Therapeutic Outcomes: A Retrospective Cohort Study in a Tertiary Hospital.药师主导的抗感染会诊对治疗结果的影响：一项在三级医院开展的回顾性队列研究
Infect Drug Resist. 2025 Jul 28;18:3735-3744. doi: 10.2147/IDR.S534678. eCollection 2025.
2
Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China.是时候仅推荐基于曲线下面积（AUC）的万古霉素治疗药物监测了吗？一项在中国的横断面调查。
Front Pharmacol. 2024 Jul 12;15:1370040. doi: 10.3389/fphar.2024.1370040. eCollection 2024.
3
Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis.
住院患者中达托霉素与万古霉素的成本核算：成本最小化分析
Open Forum Infect Dis. 2024 Apr 18;11(5):ofae217. doi: 10.1093/ofid/ofae217. eCollection 2024 May.
4
International survey of antibiotic dosing and monitoring in adult intensive care units.国际成人重症监护病房抗生素剂量和监测调查。
Crit Care. 2023 Jun 19;27(1):241. doi: 10.1186/s13054-023-04527-1.
5
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta-analysis.万古霉素药时曲线下面积与谷浓度指导给药与急性肾损伤风险：系统评价和荟萃分析。
Pharmacotherapy. 2022 Sep;42(9):741-753. doi: 10.1002/phar.2722. Epub 2022 Aug 5.